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 Acute lymphocytic leukemia (ALL) is one of the most common types of pediatric 
cancers. Improvements in treatment within the last 20 years have resulted in reduced 
mortality and a greater focus upon quality of life. Several researchers have documented 
neuropsychological impairments in children following treatment for ALL; however, there 
have not been any comparative studies documenting differences in neuropsychological 
functioning based upon treatment modality despite the documented effects of radiation 
therapy and combined radiation/chemotherapy upon the developing brain. In addition, 
past studies have focused on unitary measures, ignoring the hierarchical relationship 
between basic cognitive functions and more abstract skills. This study examined the 
neuropsychological functioning of 81 children who were treated for ALL at a 
metropolitan children’s hospital. All children were tested a minimum of two years after 
the final treatment session and were administered the NEPSY. Results do not support 
any interactions or main effects with the exception of the age of the child at diagnosis. 
Children diagnosed prior to the age of 5 showed greater impairments on tasks 
measuring attention, memory, and visuospatial reasoning in comparison to peers 
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CHAPTER 1: INTRODUCTION 
 
 
HIERCHICAL NEUROPSYCHOLOGICAL FUNCTIONING AMONG PEDIATRIC 
SURVIVORS OF ACUTE LYMPHOCYTIC LEUKEMIA 
 
Within the last 50 years, medical science has progressed at a rate unsurpassed by 
any other time era. Many diseases once considered incurable, such as cancer, are 
being treated with remarkable results and in many cases, remit. Whereas in the 1970’s 
childhood cancers such as acute lymphocytic leukemia (ALL) had a survival rate of less 
than 60% (National Cancer Institute, 2005b), epidemiological reports indicate that more 
than 87% of children afflicted with this illness achieved complete remission and were 
living normal lives in 2001 (2005b). 
However, because treatment often entails cranial irradiation therapy and intrathecal 
injection of chemotherapeutic agents into the central nervous system during a critical 
period of development, concerns regarding the long-term effects of treatment for ALL 
remain a significant concern (Moleski, 2000; Said, Waters, Cousens, & Stevens, 1989). 
Due to the high percentage of children who are enrolled in special education following 
treatment for ALL (Brown & Madan-Swain, 1993), research has primarily focused on 
cognitive functioning in these children. Beginning in the late 1970’s, studies have 
attempted to determine if standard treatment modalities result in decrements in overall 
intellectual ability, attention, and psychological adjustment. However, fewer studies 
have examined specific cognitive domains such as memory, sensorimotor abilities, and 
visuospatial skills (Butler & Copeland, 1993). 
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The long-term cognitive consequences of ALL have been further obscured by 
problems with research methodology and complex interactions among multiple 
variables (Brown & Madan-Swain, 1993; Butler & Copeland, 1993). At the present time, 
research suggests a pattern of six obstacles: variations in treatment protocols, the age 
and gender of child at diagnosis, latency between final treatment session and 
neurocognitive evaluation, use of appropriate comparison groups, measurement of 
neuropsychological functioning in pediatric populations, and a tendency to treat the 
various subcomponents of neuropsychological functioning as isolated processes that 
operate independent of one another. It is the intent of this study to delineate how each 
of these factors, both as individual variables and in combination with one another, help 
explain the variability in research findings regarding neuropsychological functioning 
among pediatric ALL survivors. 
Variations in Treatment Protocol 
For both ethical and practical reasons, it is impossible to study life-threatening 
illnesses such as cancer via experimental design; ALL cannot be induced 
experimentally nor can researchers randomly assign patients to different treatment 
groups. Consequently, the majority of research to date has been retrospective. While a 
valuable tool in studying chronic or life-threatening illnesses, retrospective studies are 
fraught with a number of methodological problems (Stehbens et al., 1994). Perhaps of 
greatest concern within the area of cancer research is that few studies control for the 
specific type of treatment (Butler & Copeland, 1993; Moleski, 2000). The long-term 
effects of radiation may differ from those caused by intrathecal chemotherapy alone or 
in combination with other treatments (Butler & Copeland, 1993; MacLean et al., 1995; 
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Moleski, 2000; Stehbens et al., 1994). Studies conducted in the late 1980’s have 
demonstrated the deleterious effects of irradiation upon the developing brain (Moleski, 
2000; Stehbens et al., 1994). Brown & Madan-Swain (1993) note that children who had 
been treated with radiation scored significantly lower than their healthy siblings on 
measures of overall intellectual functioning, visuospatial abilities, and verbal memory. 
This is consistent with other studies which have examined the specific effects of central 
nervous system irradiation and suggest a pattern of impairments on neuropsychological 
measures (Cousens et al., 1988; Moleski, 2000; Said, Waters, Cousens, & Stevens, 
1989). Even among the studies which have focused exclusively on radiation treatment, 
differences in the amount of radiation administered, length of treatment session, and 
frequency or intensity of radiation treatments have rarely been addressed (Brown & 
Madan-Swain, 1993; Butler & Copeland, 1993; Moleski, 2000). 
In comparison, intrathecal chemotherapy has been linked with similar impairments 
in neurocognitive performance, although to a much milder extent (MacLean et al., 1995; 
Moleski, 2000; National Cancer Institute, 2005a; Regan & Reeb, 1998). Because 
methotrexate (MTX) is the most commonly prescribed chemotherapeutic agent 
(Armstrong & Horn, 1995; Johnston, 1985; Mauer et al., 1993; Précourt et al., 2002; 
Stehbens et al., 1991) comparisons among children who have received intrathecal 
chemotherapy only are much easier and therefore, have greater heuristic value. 
However, problems still exist as few studies provide information regarding drug titration, 
treatment intensity (e.g. chemotherapy administered within a short time span versus 
over long period of time), and time intervals between each treatment session. Research 
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has shown that more intensive treatment sessions or higher doses of chemotherapy 
often result in more severe impairments (Copeland, 1996; Moleski, 2000). 
Past research demonstrates that neurocognitive impairments are most apparent in 
children who receive a combined treatment regimen consisting of both radiation and 
intrathecal methotrexate (Brown & Madan-Swain, 1993; MacLean et al., 1995; Moleski, 
2000; National Cancer Institute, 2005a; Stehbens et al., 1994). MacLean et al. (1995) 
notes that children who received the combined treatment performed significantly worse 
on the McCarthy Motor Scale and Token Test. A study conducted by Moleski (2000) 
found impairments in memory, metacognition, visuomotor skills, processing speed, and 
visuospatial abilities. Although Stehbens et al. (1994) failed to find any significant 
differences in cognitive performance when comparing children who received either 
combined radiation/intrathecal or intrathecal treatment only, it should be noted that all 
subjects were tested within the first 9 months after their last treatment. Due to the 
sequence of brain development, neurobehavioral alterations may not be evident until a 
later time (Brouwers et al., 1985; Fletcher & Copeland, 1988). 
Age and Gender of Child at Initial Diagnosis 
Another factor which likely influences performance on neuropsychological 
measures is the age at which the child was first diagnosed and treated. While a specific 
age has not been determined, studies indicate that young children under the age of 5 
typically manifest a greater number and more severe cognitive difficulties (Brown & 
Madan-Swain, 1993; Moleski, 2000; Regan & Reeb, 1998; Stehbens et al., 1994). 
According to a study conducted by Said et al. (1989), age at diagnosis correlated with 
lower full scale IQ (FSIQ), verbal IQ (VIQ), and perceptual reasoning abilities (PIQ) as 
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measured by the Kaufman Brief Intelligence Test (K-BIT); the younger the child was at 
diagnosis, the poorer the performance. This concurs with the findings of several other 
studies (e.g. Brown & Madan-Swain, 1993; Ciesielski et al., 1999; Moleski, 2000; 
Stehbens et al., 1994) which have linked young age at diagnosis with greater 
neuropsychological impairments over time.  
However, the negative effects of irradiation or chemotherapy during the first 5 
years of life may be mediated by type of treatment (Brown & Madan-Swain, 1993; 
Moleksi, 2000; National Cancer Institute, 2005a; Regan & Reeb, 1998). According to 
Armstrong and Horn (1995), children who received radiation therapy showed greater 
deficits in non-verbal skills in comparison to intact language abilities and abstract 
reasoning skills; however, only children who had been treated prior to the age of 5 
exhibited severe, pervasive impairments. There was a positive, linear correlation 
between age at diagnosis and perceptual motor skills among all children, including 
those who had received radiation (Regan & Reeb, 1998). Although no studies to date 
have directly compared the performance of children who received only intrathecal 
chemotherapy or radiation for the purpose of delineating cognitive impairments 
attributable to radiation versus chemotherapy, Brown & Madan-Swain (1993) note that 
age is only predictive of neurocognitive performance among children who receive 
radiation.  
Past research has alluded to the importance of gender in predicting long-term 
outcome. Several authors (e.g. Brown & Madan-Swain, 1993; Mulhernn, 1994; Smith et 
al., 2005) have demonstrated that female ALL survivors evidence greater decrements 
and more global impairments on neuropsychological measurements in comparison to 
 5
 
their male counterparts. This finding is surprising considering that males outnumber 
females 4:1 and 3:1 in the number of children diagnosed with a learning disability and 
ADHD, respectively (APA, 2002; CHADD, 2000). Both of these diagnoses have been 
linked with neuropsychological impairments and thus, it seems unusual that male ALL 
survivors would obtain higher scores in comparison to their female counterparts. 
As with age, a critical factor in understanding how female gender and 
neurocognitive performance interact may be related to treatment modality (Mulhernn, 
1994). Copeland et al. (1996) proposes that gender differences on neurocognitive 
measures are only evident when radiation is a component of treatment. In a study 
examining the effects of intrathecal methotrexate upon cognitive abilities, females did 
not evidence any clinically significant differences on measures of global intellectual 
ability in comparison to their male counterparts (Copeland, 1996). Mulhernn (1994) 
reports similar results but notes that when chemotherapy was combined with radiation, 
females performed worse on measures of perceptual abilities and overall cognitive 
functioning. Furthermore, females showed significantly greater declines in verbal skills 
following a brief delay; these effects were more pronounced with higher levels of 
radiation (Mulhernn, 1994). Although no direct comparisons between females receiving 
irradiation alone versus combined radiation/ chemotherapy have been performed, 
Copeland et al. (1996) hypothesizes that the combined treatment results in a synergistic 
effect, augmenting the deleterious effect of each individual agent upon cognitive 
functioning. Ironically, researchers (e.g. Butler & Mulhernn, 2005; Smith et al., 2005) 
note that while female gender is associated with greater vulnerability to cognitive deficits 
following treatment for ALL, it is also a factor linked with a more favorable prognosis.  
 6
 
Latency Between Diagnosis and Neuropsychological Evaluation 
Because both radiation and intrathecal chemotherapy are intended to systemically 
destroy all cancerous cells, brain structures which play a key role in higher order 
cognitive functioning may be damaged or altered (Brouwers et al., 1985; Brown & 
Madan-Swain, 1993; Fletcher & Copeland, 1988; Schatz, Kramer, Ablin, & Mathhay, 
2000; Stehbens et al., 1994). Evidence of damage to this area may not become evident 
until later in a child’s life (Brown & Madan-Swain, 1993; Packer et al., 1987; Schatz et 
al., 2000; Stehbens et al., 1994). The length of time between the final treatment session 
and neuropsychological testing thus becomes an important variable. Although recent 
studies have began to take this factor into consideration, earlier research was clouded 
by the fact that children who were less than 1 year post treatment were being compared 
to those who were tested several months or years after the final treatment session 
(Brouwers et al., 1985; Stehbens et al., 1994). Fletcher and Copeland (1988, pp. 503) 
posit that “the majority of studies conducted within 1 year of diagnosis show no 
[neurocognitive] effects, but those with a latency of 3 or more years do show a 
significant effect.” In fact, among a group of 17 pediatric ALL survivors tested six years 
after diagnosis, nearly 96% evidenced impairments on neuropsychological measures 
with the greatest deficits noted in perceptual-motor and sensory tasks (Fletcher & 
Copeland, 1988). Several authors (e.g. Brouwers et al., 1985; Moleski, 2000; Packer et 
al., 1987; Regan & Reeb, 1998; Schatz et al., 2000) note that while impairments in 
neurocognitive functioning are not usually detectable until 2-3 years after treatment; 
Brouwers et al. (1985) maintains that deficits may not become apparent until up to 7 
years later. According to Brown and Madan-Swain (1993), a child’s brain does not reach 
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full maturity until the second decade of life and thus, the longer the latency between the 
child’s age at diagnosis and chronological age, the more pervasive and severe 
impairments in neuropsychological functioning may become.  
Appropriate Comparison Groups 
 Determining the presence and severity of neuropsychological deficits is further 
compounded by a lack of appropriate comparison groups (Brown & Madan-Swain, 
1993; Giralt et al., 1992; Liu et al., 1996; Moleski, 2000; Regan & Reeb, 1998; Schatz et 
al., 2000). To control for all individual factors which might influence performance on 
neurocognitive measures, a child should ideally be tested prior to beginning treatment 
for ALL and then be re-evaluated periodically to monitor changes. Alternatively, a true 
experimental design would entail a control group of same age, sex-matched children 
who received a placebo treatment. Obviously this design could never be implemented 
as it is highly unethical to withhold treatment for a child with a life-threatening illness 
solely for research purposes. However, in order to truly discern the individual 
contributions of psychosocial, personality, and treatment factors upon cognitive 
functioning, one cannot rely upon retrospective studies (Stehbens et al., 1994). 
 Thus, in an effort to control for factors such as genetics, pre-existing medical 
conditions or brain damage, history of head injuries, and other environmental influences 
while continuing to provide children with the treatment they need, several authors (e.g. 
Brown & Madan-Swain, 1993; Kaemingk et al., 20004; Moleski, 2000; Murdoch & Boon, 
1999; Regan & Reeb, 1998; Taylor, 1997) have used healthy siblings as a basis for 
comparison. Said et al. (1989) note that in comparison to same age siblings, ALL 
survivors evidenced poorer nonverbal reasoning skills, resulting in a lower full scale and 
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performance IQ scores as measured by the WISC-IV.  This corroborates the findings of 
Moss, Nannis, and Poplack (1981) and Twaddle, Britton, Craft, Noble, and Kernahan 
(1983) who both noted that the greatest discrepancies were found on the Information, 
Similarities, Arithmetic, Comprehension, Picture Completion, Picture Arrangement, and 
Block Design subscales of the WISC-IV. Performance on these measures has been 
associated with higher level cognitive functions such as working memory, visual 
attention, spatial and sequential reasoning, and remote memory (Moss et al., 1981; 
Sattler, 1992). 
 However, the validity of these results must be interpreted with caution as there is 
some evidence that the intellectual ability of ALL siblings may not be normally 
distributed (Giralt et al., 1992; Jannoun, 1983; Moss et al., 1981; Twaddle et al., 1983). 
Giralt et al. (1992) notes that the mean IQ for healthy siblings is 112-113. According to 
Moss et al. (1981), the mean full-scale IQ for ALL survivors ranges from 98.6 to 99.9, 
whereas their healthy siblings obtained scores of 110-116. Twaddle et al. (1983) applied 
a correction formula to account for genetic variations based upon an earlier finding that 
siblings’ intellectual abilities generally correlate at a 0.5 level. Results were consistent 
with other studies which note significantly higher full-scale IQ abilities among healthy 
siblings in comparison to children who have been diagnosed with ALL (Twaddle et al., 
1983). Furthermore, this discrepancy was evident prior to the ALL group receiving any 






Measurement of Neuropsychological Functioning in Pediatric Populations 
 One criticism of past research is an over reliance upon measures not intended 
for use as neuropsychological instruments. Research is replete with studies that have 
used measures of global intellectual ability to gauge alterations in memory, attention, 
and language despite the instruments’ insensitivity to neuropsychological processes 
(Butler & Copeland, 1993; Eiser, 1992; Précourt et al., 2002; Regan & Reeb, 1998). 
This practice is likely to lead to an increased probability of a type II error in which a 
significant finding is not identified (Butler & Copeland, 1993).  While several studies 
(e.g. Brown & Madan-Swain, 1993; Espy et al., 2001; Stehbens et al., 1994) allude to 
the benefit of using a WISC-IV or Kaufman scale as an index of higher order cognitive 
abilities, research suggests that neurodevelopmental changes following treatment for 
ALL are subtle and thus, undetectable by instruments which were not intended to 
assess all of the underlying processes (Butler & Copeland, 1993; Moleski, 2000; Regan 
& Reeb, 1998). Butler and Copeland (1993, pp. 326-327) point out 
Intelligence and achievement tests are not…neuropsychological measures.  
They were not developed to assess brain-behavior relationships in children; 
Rather, intelligence and achievement tests were originally developed to predict 
and assess performance in school 
 
The use of intellectual tests also blurs the distinction between individual 
neurocognitive processes, rendering it very difficult, if not impossible, to pinpoint specific 
neuropsychological deficits (Godber, Anderson, & Bell, 2000; Précourt et al., 2002; 
Regan & Reeb, 1998). Most tasks on intellectual measures entail simultaneous use of 
different skills (Butler & Copeland, 1993; Eiser, 1992; Moleski, 2000; Reeb & Regan, 
1998). For instance, poor performance on the Maze subtest of the WISC-IV may be 
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attributable to impairments in fine motor skills, visuospatial abilities, ocular tracking, 
impulsivity, slow processing speed, or any combination of the above. Thus, conclusions 
regarding neuropsychological functioning which are based upon the results of an IQ test 
are likely neither reflective of a child’s true abilities nor predictive of performance among 
other ALL survivors. 
Another oft-used practice is to try to predict comparisons with same-age peers 
beyond the tests’ normative sample. Because the field of neuropsychology is relatively 
young and the majority of research stems from work with brain-injured adults, 
instruments designed to measure neurocognitive abilities in children and adolescents 
are sparse. There is a tendency to “project downward” or assume that cognitive 
development is a linear process in which skills are attained in increments of months or 
years (Dean, 2005; Korkman, Kirk, & Kemp, 1998). For instance, Stehbens (1994) 
notes that the norms for adolescents 14 years old or older on the Rey Auditory Verbal 
Learning Test (RAVLT) are all less than one standard deviation, which results in a score 
that overestimates the degree of neurological impairment. Furthermore, Dean (2005) 
adds that although efforts have been made to modify the tasks of Halstead-Reitan Test 
Battery for use with pediatric populations, the child version is essentially the same as 
the original; thus, the Halstead-Reitan Test Battery for Children is “but a downward 
revision of the adult battery” (p. 2). 
Finally, past studies have relied almost exclusively on measures not intended for 
use as neuropsychological instruments or those not specifically designed for children 
(Dean, 2005; Korkman et al., 1998). The Halstead-Reitan Neuropsychological Battery 
(HRNB), provides an index of neuropsychological impairment based on a 4 point rating 
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scale (1= average, 2=one standard deviation below the mean, 3= two standard 
deviations below the mean, and 4=three standard deviations below the mean) but fails 
to provide information concerning specific areas of cognitive strength or weakness 
(Dean, 2005; Hebben & Milberg, 2002). Furthermore, the intent of the HRNB is not to 
tease out specific areas of neuropsychological impairment, but to differentiate 1) organic 
neurological dysfunction from normal populations, 2) organic neuropsychological 
dysfunction from specific psychiatric populations, 3) focal from diffuse brain damage, 
and 4) regional focal dysfunctions in various zones of the brain (Dean, 2005). 
Information concerning norms and standardization are not provided and thus, 
transformation of raw data into standardized scores that provide a basis for individual 
comparisons is impossible (Dean, 2005).  The HRNB is founded upon the theory that all 
brain regions are equally responsible for cognitive functions; thus, skills cannot be 
localized to specific areas, necessitating administration of the entire test battery in order 
to determine areas of deficits (Dean, 2005; Hebben & Milberg, 2002). As a result, 
children may quickly lose interest in the materials or become too fatigued to complete 
the entire battery to the best of their ability (2002).  
In comparison, the Luria-Nebraska is efficacious in assessing levels of 
neuropsychological dysfunction, but has been criticized for being insensitive to 
language impairments (2002). Presently, neither the Halstead-Reitan nor the Luria-
Nebraska neuropsychological batteries provide norms for children younger than 8 and 6 
years of age, respectively (2002). As Stehbens (1994, p.) points out, “it is notable that 
few neuropsychological instruments have been normed on pre-school age children, a 
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group that has been identified as being at the greatest risk for neurocognitive 
impairment.” 
Neuropsychological Functioning as Hierarchical Model 
In an effort to pinpoint specific underlying neurocognitive deficits which influence 
more complex processes, the use of a hierarchical model in which basic skills are 
evaluated prior to testing higher order functions is recommended (Lockwood, Bell, & 
Colegrove, 1999). Just as it is necessary to rule out more simple diagnoses for a patient 
who complains of chest pain prior to conducting open-heart surgery, a clinician would 
be remiss in identifying deficits in complex cognitive processes without first addressing 
base skills. Thus, before impairments in memory or language can be determined, it is 
important to first evaluate sensory (i.e. hearing, vision) and attentional processes 
(Lockwood, Bell, & Colegrove, 1999). This notion of hierarchical cognitive functioning 
was first proposed by Aleksandr Luria in 1966 (Hebben & Milberg, 2002). Luria 
maintained that complex cognitive skills are comprised of elementary building blocks 
that function as lower-level cognitive processes (2002). 
 To date, most studies have assessed the various components of cognition as 
unitary processes that operate independent of each other. Past literature suggests that 
among studies which have attempted to measure both intellectual ability and other 
cognitive functions such as memory or visuospatial skills, most have examined these 
factors in isolation of each other, as if processes such as attention and memory operate 
independent of one another. Results of cognitive batteries and brain imaging studies 





Functional anatomic studies clearly indicate that multiple brain regions can be  
 activated by memory and learning tasks and may participate in neural processing 
 to different degrees; thus, performance on a memory task may not only be a  
function of memory, but of additional cognitive and neuroanatomical components 
such as attentional, visuoperceptual, and motor abilities. 
 
 Subsequently, past studies which have employed a piece-meal approach in 
which inter-related cognitive functions are treated as distinct entities independent of 
each other likely mask the true nature and complexity of cognitive impairments.  
Pathogenesis of Acute Lymphocytic leukemia. 
ALL occurs when the bone marrow begins to produce abnormal cells at an 
uncontrolled rate (Rubnitz & Look, 2000). Many different blood cells originate in the 
bone marrow & then differentiate into specialized cells such as erthryocytes (red blood 
cells) and lymphoblasts (white cells) after migration to other parts of the body (Guyton & 
Hall, 1996). Normally, the body maintains a strict balance of each kind of blood cell so 
that no one specific type overwhelms the others. In ALL, the cells responsible for cell-
mediated and humoral immunity, the lymphocytes, grow uncontrolled, causing normal, 
healthy cells to be crowded out (Rubnitz & Look, 2000). Diminished red cell levels result 
in fatigue and pallor while decreased numbers of healthy white cells interfere with the 
body’s ability to ward off infection and recover from injury (National Marrow Donor 
Program, 2005). As the most common childhood cancer, ALL accounts for more than 
31% of newly diagnosed cancers every year (Smith, Ries, Gurney, & Ross, 2005). It is 
typically diagnosed between the ages of 2-3 years although it can occur in infancy and 
adulthood (Center for Disease Control, 2005; Smith et al., 2005). The male to female 
ratio is 2:1; however, females are more likely to experience central nervous system late 
effects (Berg, Steuber, & Poplack, 2000; Espy et al., 2001). As recent as the 1960’s, 
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ALL was largely untreatable, claiming the lives of nearly 2000 children annually 
(National Cancer Institute, 2005b). However, with the advent of radiation therapy and 
chemotherapeutic agents which eliminate cancerous cells throughout the entire body, 
the survival rate has increased to nearly 90% (National Cancer Institute, 2005b). 
 Because the cancer cells are interspersed with other cellular components of 
blood, there is a possibility that cancerous cells will be carried to the brain and tissue of 
the central nervous system (Moleski, 2000; National Marrow Donor Program, 2005). 
The brain normally forms a barrier, preventing toxic agents from infiltrating the central 
nervous system; subsequently, chemotherapeutic drugs are unable to cross from the 
blood to the brain and cancer cells may proliferate (Berg et al., 2000). Therefore, it is 
sometimes necessary to augment chemotherapy with radiation to completely rid the 
body of all cancerous cells (Berg et al., 2000; Moleski, 2000). Research suggests that a 
failure to provide systemic therapy may greatly increase the risk of relapse (Berg et al., 
2000: Moleski, 2000).  
 Presently, the most common form of treatment for ALL is intrathecal 
chemotherapy typically using methotrexate combined with one or more of the following: 
vincristine, asparaginase, prednisone, and cyclosporine (Ghalie et al., 1990; Johnston, 
1985; Mauer, 1983; Memon et al., 1995; Menegaux et al., 1994; Nussbaum et al., 1995; 
Silverman, Sallen, & Cohen, 2000). Because few agents are able to cross the blood-
brain barrier on their own, methotrexate must be injected directly into the spine to 
facilitate the destruction of cancer cells which have migrated into the central nervous 
system (Dufner et al., 1984; Mauer, 1983; Précourt et al., 2002). However, because 
methotrexate does not show a greater affinity for the cancerous cells, healthy cells are 
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often destroyed in the process as well (Armstrong & Horn, 1995; Menegaux et al., 1988; 
Mulhernn, 1994). This results in an increased risk for encephalopathies, seizures, 
cortical blindness, poor motor control, and difficulties with attention as well as memory, 
(Armstong & Horn, 1995; Ghalie et al., 1990; Johnston, 1985; Mauer, 1983; Memon et 
al., 1995; Menegaux et al., 1994; Mulhernn, 1994; Nussbaum et al., 1995; Silverman et 
al., 2000). Over an extended period of time, brain cells may be permanently damaged, 
resulting in an increased risk of impairments in neurocognitive functioning (Armstong & 
Horn, 1995; Ghalie et al., 1990; Johnston, 1985; Mauer, 1983; Memon et al., 1995; 
Menegaux et al., 1994; Mulhernn, 1994; Nussbaum et al., 1995; Silverman et al., 2000). 
 While cranial radiation is a less favorable treatment option as a result of its 
deleterious effects on the developing brain (Dufner et al., 1984; Johnston, 1985; Packer 
et al., 1987), it is sometimes used in conjunction with intrathecal chemotherapy in cases 
where there is extensive infiltration of the central nervous system or a high risk of 
relapse (Moleski, 2000). It has been postulated that the combination of intrathecal 
methotrexate and cranial irradiation creates a synergistic effect, augmenting the 
destruction of both cancerous and healthy cells to a degree much greater than what 
would be expected if each of these agents are used in isolation (Dufner et al., 1984; 
Frutiger, Fennell, & Parsons, 1999; Johnston, 1985; MacLean et al., 1995; Mauer, 1983; 
Schatz et al., 2000; Stehbens et al., 1991). Research indicates that methotrexate, as 
well as other chemotherapeutic agents, lowers the blood-brain barrier threshold, 
intensifying the effects of radiation (Copeland, 1996; Dufner et al., 1984; Mauer, 1983; 
National Cancer Institute, 2005a). 
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Structural Alterations as a Result of Radiation and Intrathecal Chemotherapy 
 Autopsies suggest that the cumulative effect of chemotherapy, irradiation, or any 
combination of the two is structural brain damage (Moleski, 2000; Reeb & Regan, 1998; 
Stehbens et al., 1994;). It is this damage that underlies the purported alterations in 
attention, memory, verbal skills, and nonverbal reasoning abilities in ALL survivors 
(Brown & Madan-Swain, 1993; Moleski, 2000; Reeb & Regan, 1998; Stehbens et al., 
1994). Functional MRI’s and brain dissections support 3 primary areas of structural 
damage: demyelinization, cortical atrophy, and calcifications in gray matter (Frutiger, 
Fennell, & Parsons, 1999; MacLean et al., 1995; Moleski, 2000; Stehbens et al., 1991; 
Stehbens et al., 1994).  
Beginning in early childhood, the body begins the process of coating nerve cells 
with a fatty sheath, known as myelin or white matter. This sheath serves several 
functions including increased speed of neural transmission and rapid repolarization 
(Guyton & Hall, 1996). Unlike other brain structures, which are typically intact by the age 
of 4 (Brown & Madan-Swain, 1993), myelinization continues throughout childhood and 
into early adulthood (Brown & Madan-Swain, 1993; Stehbens et al., 1994). Both 
chemotherapy and cranial irradiation have been shown to disrupt this process (Fletcher 
& Copeland, 1988; Moleski, 2000; Reeb & Regan, 1998; Schatz et al., 2000; Stehbens 
et al., 1994). According to Packer et al. (1987), methotrexate in particular inhibits the 
formation of a key lipid involved in myelin formation. Because the basal ganglia and 
frontal lobe extensions are the areas undergoing the most intense myelinization during 
childhood, neuropsychological impairments are likely to be the most pronounced on 
measures associated with fine motor skills, attention, executive functions, verbal 
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memory, and mathematic abilities (Brown & Madan-Swain, 1993; Fletcher & Copeland, 
1988; Moleski, 2000; Reeb & Regan, 1998). 
Although ALL survivors do not evidence the same pattern of neurocognitive 
deficits, which would suggest diffuse damage, researchers have noted that most 
impairments are concentrated in the right hemisphere (Brown & Madan-Swain, 1993; 
Reeb & Regan, 1998; Stehbens et al., 1994). This is consistent with findings of 
decreased white matter as several authors (e.g. Goldberg & Costa, 1981; Kaemingk et 
al., 2004) note that there is proportionately more white matter in the right hemisphere in 
comparison to the left hemisphere. A reduction in white matter has been linked with 
nonverbal impairments such as inattention, poor auditory memory, decreased 
processing speed, and visuospatial abilities (Brown & Madan-Swain, 1993; Fletcher & 
Copeland, 1988; Reeb & Regan, 1998; Stehbens et al., 1994).  
Cushioned beneath the insulating layers of the myelin sheath, the cerebral cortex 
contains the brain structures that govern sensory and motor functioning, information 
processing, memory, organizational/ planning abilities, emotions, and homeostasis of 
the body (Lezak, Howieson, & Loring, 2004). Within the cranium is also four fluid-filled 
cavities known as ventricles; these ventricles help maintain the shape of the cerebral 
cortex by expanding or shrinking according to tissue volume (Lezak et al., 2004). Thus, 
when brain tissue deteriorates or dies, the ventricles expand via an influx of 
cerebrospinal fluid (2004). Post mortem examinations of the brains of children afflicted 
with ALL reveals enlargements in the 4th ventricle, suggesting cortical atrophy (Lezak et 
al., 2004; Moleski, 2000). In a study conducted by Moleski (2000), nearly 80% of cortical 
atrophy was attributable to intrathecal administration of methotrexate. Paakko et al. 
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(1996) found that while white matter changes were found in only a small (10%) 
proportion of children who were being treated for ALL with a combined radiation/ 
intrathecal methotrexate regimen, 72% of the children showed enlargement of the 
ventricles and cortical sulci following administration of intrathecal methotrexate. 
According to Quinn et al. (1997), methotrexate increases homocysteine levels, which 
causes damage to vascular endothelium and thereby causes subsequent cortical 
atrophy. 
While the precise mechanism of structural damage following treatment for ALL is 
unknown, Packer et al. (1987) proposes that radiation can cause alterations via three 
pathways. At the very minimum, radiation causes damage to capillary endothelial cells, 
resulting in mutation (1987). Ultimately these mutations may result in decreased 
capillary wall permeability and subsequent decreases in vascularization (National 
Cancer Institute, 2005a) which leads to cellular necrosis (1987). Second, radiation 
damages both glial and oligodroglial cells, causing disruptions in the formation of myelin 
(1987). Finally, Packer et al. (1987) proposes that the damage to the above cells results 
in the release of antigens, activating an immunological response.  
Psychosocial Influences 
 The neuropsychological impairments brought about by treatment for ALL appear 
to be further mitigated by several psychosocial variables. Given the present disparities 
between the affluent and the poor in healthcare coverage and subsequent access to the 
most technologically advanced treatment facilities, it does not come as a surprise that 
both socioeconomic status and parental education level influence neuropsychological 
performance in ALL survivors (Espy et al., 2001; Heaton, Grant, & Mathews as cited in 
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Butler & Copeland, 1993; Said et al., 1989). According to Trautmann et al. (1988), 
parental socioeconomic status exceeds all other factors in predicting overall intellectual 
abilities. This is consistent with earlier studies of environmental influences upon 
intellectual development which emphasize the link between higher parental education 
level and increased income, which is typically associated with an enriched learning 
environment (Turner, Lewis, & King, 2003). Said et al. (1989) note that paternal 
education level, specifically, accounts for a significant amount of variance on the 
Arithmetic, Vocabulary, Digit Span, Picture Arrangement, Block Design, and Coding 
subtests of the WISC-IV as well as measures of reading comprehension and word 
recognition. Espy et al. (2001) adds that maternal education level also reliably predicts 
performance on the Arithmetic subtest of the WISC-IV 4 years post-diagnosis: for every 
year of maternal formal education beyond high school, a child’s score increases by 2.54 
points. 
Neuropsychological Domains Affected by Treatment for ALL 
Sensorimotor Skills 
 With the exception of one study completed in the late 1980’s by Copeland et al. 
(1988), few studies have specifically addressed the impact of intrathecal chemotherapy 
and radiation upon sensorimotor functioning. This is surprising given that the basal 
ganglia, a structure believed to play a pivotal role in both gross and fine motor 
movements, is one of the areas most affected by chemotherapy and radiation. 
Copeland et al. (1988) reports that children who received triple intrathecal 
chemotherapy (methotrexate combined with cytosine arabinoside, hydrocortisone, 
systemic steroids) or intravenous methetrexate performed significantly worse on 
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measures of fine-motor skill integration (e.g Finger Tapping, Grooved Pegboard, Trails 
A & B) and tactile-perceptual abilities one year after diagnosis. In fact, Rourke (1987) 
asserts that due to the underlying cause of fine-motor skill and tactile-perceptual skills, 
sensorimotor abilities should be the target of early intervention aimed at teaching the 
child compensatory behaviors prior to destruction of white matter.  
Attention 
 One of the most frequently reported long-term impairments stemming from 
treatment for ALL is attentional difficulties (Anderson et al., 1997; Armstrong, Blumberg, 
& Toledano, 1999; Brown & Madan-Swain, 1993; Ciesielski et al., 1999; Heukrot et al., 
1988; Inati et al., 1983; Lesnik et al., 1998; Lockwood et al., 1999; Précourt et al., 
2002). Preliminary studies relied upon single measures of attention, thereby yielding 
equivocal results. It has only been within the last ten years that researchers have begun 
to accept a multidimensional attention model. Cohen (1993) asserts that since various 
components of attention overlap with different sensory systems (e.g. vision, hearing, 
movement), it is imperative that a unitary measure of attention not be used to represent 
the different facets. He further notes that standardized intelligence tests are insufficient 
in assessing attention as the aforementioned is a measure of cognitive capacity, not 
attentional capacity. Lezak (2004, pp. 22-23) asserts, “attentional functions differ from 
[cognitive] functions…in that they underlie, and in a sense, energize the activity of the 
cognitive functions.” 
 Thus, it is important to differentiate among the different types of attention (Lezak 
et al., 2004; Lockwood et al., 1999; Van Zomeren & Brouwer, 1994). Van Zomeren and 
Brouwer (1994) define selective attention as the process of focusing on one set of 
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stimuli while ignoring other sources of sensory information. Divided attention, on the 
other hand, refers to the ability to attend to two or more sensory inputs simultaneously 
such as taking notes during a lecture while visually scanning a textbook (1994). 
Sustained attention requires the capacity to focus on one source of information for a 
prolonged period of time and alternating attention relates to being able to switch from 
one information source to another in a continuous fashion (1994). All four types of 
attention require different skills and provide valuable information concerning cognitive 
functioning.   
Memory 
 Because attention is a prerequisite for remembering information (Van Zomeren 
& Brouwer, 1994) and ALL survivors evidence altered attentional abilities, it does not 
come as a surprise that a number of studies have found decrements in memory and 
learning abilities in children who have been treated for ALL (Ciesielski et al., 1999; 
Précourt et al., 2002). Précourt et al. (2002) notes that children who were treated with 
either radiation or intrathecal chemotherapy alone exhibited a slower learning curve in 
comparison to healthy controls on the California Verbal Learning Test (CVLT); however, 
after multiple exposures and rehearsal of information, the intrathecal chemotherapy 
group performed at a range comparable to healthy controls. 
 Consistent with the hierarchical model of neuropsychological functioning, 
“memory” is actually comprised of a number of different skills and results are more 
readily understood when each component is analyzed separately.  For instance, the 
ability to recall visual material is governed by the visual association area of the occipital 
lobe whereas auditory information is processed in the superior temporal region (Lezak 
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et al., 2004). Simply stating that an individual exhibits compromised or impaired memory 
abilities has little diagnostic or therapeutic value. According to Lezak et al. (2004), the 
ability to recall previously learned information actually entails three separate processes: 
input, storage, and retrieval. Input involves processing and interpreting information from 
sensory organs prior to storage. During the storage process, processed information is 
transferred from the primary sensory cortex to adjacent association areas (Lezak et al., 
2004). Retrieval entails locating previously acquired information (2004). Thus, each of 
these processes must be examined separately to determine where deficits originate. 
Working memory. Schatz et al. (2000, pp. 190) defines working memory as “the 
ability to temporarily maintain and manipulate information in a limited capacity system.” 
Information from the senses must first be processed and categorized before it is 
encoded into storage. Poor performance on working memory tasks suggest that either 
information is not being sent from the sensory systems, or, that information is not being 
properly encoded once it reaches the brain. A review of the literature reveals only one 
formal study of working memory abilities in ALL survivors (Schatz et al., 2000). Schatz 
et al. (2000) reports that while some ALL survivors evaluated 30 months after diagnosis 
evidence impairments in working memory, these deficits are not uniform. Thus, 
alterations in working memory abilities following treatment for ALL are likely to be subtle 
if detectable at all (2000). Impairments in working memory are more likely to be 
pronounced in children who are treated with radiation, however (2000), Schatz et al. 
(2000) proposes that radiation interferes with both encoding and rehearsal, thereby 
producing poorer performance on neurocognitive tasks.   
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 Visual memory. Consistent with past research which suggests greater 
impairments in nonverbal abilities, the preponderance of evidence suggests impaired 
visual memory abilities among ALL survivors (Ciesielski et al., 1999; Mulhernn, 1994; 
Regan & Reeb, 1998). Ciesielski et al. (1999) notes that autopsies of children treated 
for ALL reveal extensive damage to the mammilary bodies of the frontal lobes, a 
structure believed to play a pivotal role in visuospatial memory in both humans and 
primates. This corroborates the findings of Regan and Reeb (1998) who found that ALL 
survivors performed significantly below healthy controls on the bead memory subtest of 
the Stanford-Binet as well as immediate recall of the complex figure test. In a meta-
analysis conducted by Mulhernn (1994), ALL survivors scored below expected norms 
on four out of six measures of visual memory. 
 Verbal memory. Although less often included as a dependent variable in studies 
evaluating neuropsychological impairment among ALL survivors, there is some 
evidence that auditory memory is negatively affected by radiation and intrathecal 
chemotherapy as well. Brown and Madan-Swain (1993) note that overall, survivors of 
ALL performed below expected norms on measures of auditory memory. However, 
although both the radiation and intrathecal chemotherapy group scored below their 
healthy siblings, children who had been treated with radiation did not differ from those 
who had received intrathecal chemotherapy or other treatments (1993). Other studies 
(e.g. Ciesielski et al., 1999; Kaemingk et al., 2001; Schatz et al., 2000) indicate that 
while ALL survivors may initially perform worse on single-trial verbal memory tasks, 
repeated exposure and rehearsal of auditory stimuli eliminate any discrepancies 
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between ALL survivors and healthy controls, which would suggest that impairments lie 
within the domain of learning as opposed to memory. 
Executive Functioning.  
Executive functioning is comprised of several different skill areas such as 
planning, processing, sequencing, and shifting from one task to another. However, past 
research has focused almost exclusively on processing speed as an indice of overall 
executive functioning. While Brown and Madan-Swain (1993) argue that 
neuropsychological deficits in executive functioning are variable and specific to the 
individual, several studies have found a consistent pattern of impairments in processing 
speed and planning abilities (Ciesielski et al., 1999; Heukrodt et al., 1988; Schatz et al., 
2000).  
A pivotal factor in predicting performance appears to be the interaction of the 
specific treatment modality used and age at diagnosis. Regan and Reeb (1998) report 
greater impairments in processing speed in children who received a combination of 
radiation and intrathecal chemotherapy in comparison to both healthy controls and 
children who received the chemotherapy treatment only. However, this finding is based 
upon differences in performance on the symbol search and coding/ digit span subtests 
of the WISC-IV. Butler and Copeland (1993) emphasize that the WISC-IV was not 
intended to detect subtle differences in processing speed or to provide an index of 
neuropsychological abilities. Thus, readers must be cautious in interpreting the validity 





 Among studies which have focused specifically on the effects of intrathecal 
chemotherapy upon processing speed, Heukrodt et al. (1988) proposes a linear 
relationship between methotrexate dosage and decrements in processing speed: as the 
dose of methotrexate increases, the longer the latency in processing speed. Ciesielski 
et al. (1999) reports similar results, although they note that only ALL survivors who had 
been diagnosed prior to the age of 5 showed delays in processing speed. 
Language 
 Preliminary studies of language abilities following treatment for ALL suggest mild 
impairments in both expressive and receptive skills (Anderson et al., 1994; Brown & 
Madan-Swain, 1993; Espy et al., 2001; Johnston, 1985; Précourt et al., 2002; Taylor, 
1987). Deficits have been noted in verbal reasoning (Johnston, 1985; Précourt et al., 
2002), word fluency (Espy et al., 2001; Murdoch & Boon, 1999; Taylor, 1987), reading 
comprehension (Brown & Madan-Swain, 1993), and the ability to follow multi-step oral 
commands (Johnston, 1985; Murdoch & Boon, 1999). However, some authors (e.g. 
Brown & Madan-Swain, 1993; Précourt et al., 2002) maintain that these difficulties are a 
function of impairments in attention and memory and thus, are not truly language 
problems. Précourt et al. (2002) notes that ALL survivors were differentiated from 
controls by their performance on four of the subtests comprising the freedom from 
distractibility score; these subtests entail long-term retrieval, abstract reasoning, and 
lexical attention and thus, are not a pure measure of language skills. Conversely, Taylor 
et al. (1987) evaluated 52 children using the Token test, a reliable instrument that 
specifically targets language comprehension and word fluency skills; in comparison to 
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their healthy siblings, the children treated for ALL performed significantly worse on both 
measures (Taylor, 1987) 
The discrepancies in research findings may be partially explained by the 
developmental stage of the child at diagnosis (Brown & Madan-Swain, 1993; Reeb & 
Regan, 1998). The critical period for language acquisition occurs prior to the age of 4 
(Brown & Madan-Swain, 1993; Pinker, 1995); thus, children diagnosed and treated 
during the pre-school years are more likely to demonstrate language deficits than those 
who are treated at an older age.  
In spite of the above findings, several authors (e.g. Johnston, 1985; Murdoch & 
Boon, 1999) maintain that the true extent of language impairments among ALL 
survivors remains unknown as a result of over-reliance upon IQ tests to measure 
language functioning. Historically researchers have depended upon VIQ-PIQ splits and 
subtest scatter to predict both receptive and expressive language problems. Murdoch & 
Boon (1999) maintain that even studies which have used appropriate language-based 
measurements fail to support the broad conclusions about the deleterious effects of 
central nervous system therapy upon children afflicted with ALL. For instance, a study 
conducted by Copeland (1996) concluded that language abilities are unaffected by 
central nervous system therapy; however, these findings were based upon ALL 
survivors’ performance on three brief semantic measures, which Murdoch & Boon 




 There is little disagreement as to alterations in visuospatial abilities following 
treatment for ALL; virtually all studies suggest impairments in visual-motor integration 
(Brown & Madan-Swain, 1993; Brown et al., 1998; Ciesielski et al., 1990; Kaemingk et 
al., 2004; Lesnik et al., 1998; National Cancer Institute, 2005a; Précourt et al., 2002; 
Regan & Reeb, 1998). Greater decrements have been noted among patients receiving 
a combined radiation/ intrathecal chemotherapy treatment (Brown et al., 1998; Espy et 
al., 2001; Lesnik et al., 1998; Regan & Reeb, 1998). According to Espy et al. (2001), 
children who had been treated with both radiation and chemotherapy evidenced an 
average decrease of 3.12 points per year on the Beery-Burrkey Visual Motor Integration 
Test in comparison to an average decrease of .95 points for the chemotherapy-only 
group; over a four year time span, the discrepancy between the two groups increased, 
with the combined treatment group scoring 12 points lower than the chemotherapy-only 
group.  Frutiger et al. (1999) note that decrements in visuospatial abilities may persist 
even after treatment ceases and other visual processes have returned to normal.  
 However, researchers do not agree on which processes are the most affected. 
Like memory, visuospatial abilities can be subdivided into input processes, output 
processes, and integration of visual and motor skills (Brown & Madan-Swain, 1993; 
Regan & Reeb, 1998). Although several researchers have suggested impairments in 
visual organization (Regan & Reeb, 1998) and fine motor speed (Espy et al., 2001; 
Schatz et al., 2000), no study to date has undertaken the task of measuring each 




 The preponderance of research supports a decline in intellectual functioning 
following treatment for ALL (Brown & Madan-Swain, 1993; Cousens, 1988; Kaemingk et 
al., 2004; Mulhernn, 1994; Said et al., 1989; Schatz et al., 2000). Most ALL survivors 
evidence decrements of  2/3 to 1 standard deviation, or approximately 10-11 points, on 
standard intellectual measures within 7 years following treatment (Brown & Madan-
Swain, 1993; Cousens, 1988; Said et al., 1989; Schatz et al., 2000). Although the 
nature of most intellectual measures render it impossible to pinpoint specific areas of 
impairment, it has been hypothesized that the decrements in intellectual functioning are 
attributable to impairments in motor agility, memory, and problem solving (Brown & 
Madan-Swain, 1993; Schatz et al., 2000; Waber, Isquith, & Kahn, 1994). As with other 
measures of cognitive abilities, the younger the age of the child at diagnosis, the poorer 
the performance on measures of global intellectual ability (Said et al., 1989). Preliminary 
research has not found a relationship between intellectual functioning and treatment 
modality (Williams et al., 1986). In a study conducted by Williams et al. (1986), children 
who received 2400 Gy of radiation performed at the same level as their peers who had 
been treated with much lower doses of radiation. Précourt et al. (2002) notes that 
children treated with intrathecal methotrexate did not differ from controls on the WISC-
III.  
Academic Achievement 
 Given the importance of higher education in attaining career goals, it is not 
surprising that academic achievement has been used to gauge the ecological validity of 
studies concerning cognitive difficulties in ALL survivors. Nearly 1/3 of children who 
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have been treated for ALL evidence academic problems sufficient to meet eligibility for 
special education (Mauer et al., 1993; Stehbens et al., 1991). This number may 
underestimate the true extent of learning problems attributable to cancer treatment as 
Stehbens et al. (1991) notes that over 70% of ALL survivors have sought academic 
remediation both within and outside of the school environment. Studies indicate that 
impairments are most frequently found in mathematical abilities and spelling (Brown & 
Madan-Swain, 1993; Espy et al., 2001; Kaemingk et al., 2004; Kleinman & Waber, 
1992; Martin, 2002; Moleski, 2000; Said et al., 1989; Temple, 1997). 
 Although several authors (e.g. Brown & Madan-Swain, 1993; Said et al., 1989) 
have noted mathematical impairments as evidenced by poor performance on the 
arithmetic, digit span, and coding subtests of the WISC-R and WISC-IV, Kaemingk et al. 
(2004) maintains that both math reasoning and math application skills must be 
addressed before concluding that a child has a math disability. The majority of studies 
which have examined academic achievement in ALL survivors typically rely upon 
information obtained as part of intellectual assessment (Kaemingk et al., 2004). Both 
the arithmetic and digit span subtests of the WISC-IV are heavily reliant upon working 
memory whereas coding is more predictive of visuomotor integration, short-term 
memory, and attention as opposed to mathematical ability (Sattler, 1992).  
 In regard to reading and spelling abilities, research suggests impairments in 
phonological skills, but not orthographic abilities (Kleinman & Waber, 1992). According 
to Kleinman and Waber (1992), the frequency of phonological errors was more 
pronounced in children who had been treated for ALL prior to the age of 5. Thus, it 
appears that deficits in reading and spelling, as well as verbal fluency, may be a result 
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of poor understanding of the relationship between letters and sounds in contrast to a 
true aphasia (Hebben & Milberg, 2002; Kleinman & Waber, 1992).  
Summary and Rationale for Research Study 
 Based on the information above, it is evident that past efforts to assess 
neuropsychological functioning in ALL survivors have been confounded by six factors: 
(1) variations in treatment protocols (Brown & Madan-Swain, 1993; Butler & Copeland, 
1993; Moleski, 2000; Schatz et al., 2000; Stehbens et al., 1994); (2) the age and gender 
of child at diagnosis (Brown & Madan-Swain, 1993; Copeland et al., 1996; Moleski, 
2000; Mulhernnn, 1994; NCI, 2005a; Regan & Reeb, 1998; Smith et al., 2005; Stehbens 
et al., 1994); (3) latency between final treatment session and neurocognitive evaluation 
(Brouwers et al., 1985; Brown & Madan-Swain, 1993; Fletcher & Copeland, 1988; 
Packer et al., 1987; Schatz et al., 2000; Stehbens et al., 1994); (4) use of appropriate 
comparison groups (Brown & Madan-Swain, 1993; Giralt et al., 1992; Jannoun, 1983; 
Liu et al., 1996; Moleski, 2000; Moss et al., 1981; Regan & Reeb, 1998; Schatz et al., 
2000; Twaddle et al., 1983); (5) measurement of neuropsychological functioning in 
pediatric populations (Butler & Copeland, 1993; Eiser, 1992; Précourt et al., 2002; 
Regan & Reeb, 1998); and (6) a tendency to treat the various subcomponents of 
neuropsychological functioning as isolated processes that operate independent of one 
another (Ciesielski et al., 1999; Lockwood et al., 1999; Hebben & Milberg, 2002). While 
both past and current research in this area provides a strong foundation upon which 
future studies can elaborate on specific areas of impairment among ALL survivors, 
results have been equivocal and insufficient to identify effective interventions. 
Furthermore, despite conclusive results from neuroimaging studies which support a 
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hierarchical model of neuropsychological functioning (Ciesielski et al., 1999; Hebben & 
Milberg, 2002), no study to date has addressed the relative influence of more basic 
cognitive abilities in predicting performance on higher-order tasks such as executive 
functioning or language. Thus, it is the intent of this study to address 
neuropsychological impairments in ALL survivors using a hierarchical model in which 
deficits in “basic” cognitive skills, such as sensory awareness and attention, are taken 
into account prior to examining more complex functions such as executive functioning. 
Specifically, the following hypotheses will be addressed: (1) differences in sensorimotor 
skills, attention, memory, and visuospatial skills as a function of specific treatment type; 
(2) influence of latency between final treatment session and neuropsychological testing; 
(3) covariate effect of age as a predictor of performance on neuropsychological 
measures; (4) differences on neuropsychological measures as a function of gender; (5) 
performance on the NEPSY in comparison to past research studies which have 
documented impairments in sensorimotor abilities, attention, memory, and visuospatial 
skills; and (6) hierarchical structure of neuropsychological functioning in survivors of 
ALL. 
Hypothesis 1: Performance on Neuropsychological Measures Will Fall on a Continuum 
with the Combined Treatment Group Showing the Greatest Impairments, Followed by 
the Radiation-Only Group, and Then the Chemotherapy-Only Group. 
Past research has demonstrated that both cranial irradiation and intrathecal 
administration of specific chemotherapeutic agents such as methotrexate can have 
deleterious effects upon the developing brain (Butler & Copeland, 1993; MacLean et al., 
1995; Moleski, 2000; Stehbens et al., 1994). While no study to date has made direct 
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comparisons of neuropsychological functioning among children treated with radiation, 
chemotherapy, or a combination thereof, research has shown that methotrexate and 
other commonly used chemotherapeutic agents augment the effects of radiation 
treatment (Copeland, 1996; Dufner et al., 1984; Mauer, 1983; NCI, 2005a). However, 
past research efforts have focused on comparisons between children diagnosed with 
ALL and 1 of 2 control groups: (1) age-matched peers who have undergone similar 
treatment protocols for brain tumors, or (2) healthy siblings of ALL patients. While the 
former provides valuable information regarding the specific impact of the ALL disease 
process upon cognitive functioning and the latter controls for genetic influences, neither 
addresses the question of how different treatment modalities affect neuropsychological 
functioning among ALL survivors. Subsequently, it is hypothesized that children who 
received combination treatment will demonstrate poorer performance on measures of 
sensorimotor skills, attention, memory, and visuospatial skills. Furthermore, given the 
wealth of research which has documented both the short-term and long-term alterations 
in neurocognitive functioning as a result of radiation treatment, it is expected that 
children who received radiation-only treatment will evidence greater impairments on the 
aforementioned neuropsychological domains in comparison to children who were 
treated solely with chemotherapy. Thus, in comparing all three treatment modalities, it is 
anticipated that performance on neurocognitive measures will fall on a continuum with 




Hypothesis 2: Impairments in Neuropsychological Functioning Will be Apparent a 
Minimum of 2 Years Post-Treatment. 
It is important to note as well that when a child is evaluated in relation to initial 
diagnosis can substantially affect performance on neuropsychological measures. Due to 
the gradual, continuous maturation of the brain during childhood & structural alterations 
that result in neuropsychological impairments that are not evident until later stages of 
development, ALL survivors may not evidence signs of neurocognitive impairments until 
several years later. While an exact latency period between initial diagnosis and 
evidence of neuropsychological alterations has not been established, past studies 
suggest that children should not be evaluated any earlier than one year after their final 
treatment. Consistent with this finding, it is hypothesized that children who were 
assessed a minimum of two years after treatment will show neurocognitive impairments. 
Hypotheses 3: Performance On Neuropsychological Measures Will Vary with Age, with 
Children Who Were Diagnosed Prior to the Age of 5 Showing Greater Impairments in 
Comparison to Children Diagnosed with ALL After Age 5. 
Research has also demonstrated a link between both age at diagnosis and 
gender in predicting long-term cognitive functioning (Brown & Madan-Swain, 1993; 
Butler & Copeland, 1993; Moleski, 2000; Regan & Reeb, 1998; Stehbens et al., 1994). 
Because the brain and central nervous system continue to mature throughout childhood 
and young adulthood, children who are diagnosed with ALL at a young age are at an 
increased risk for difficulties with attention, concentration, memory, fine motor skills, and 
visuospatial abilities (Brown & Madan-Swain, 1993; Fletcher & Copeland, 1988; Guyton 
& Hall, 1996; Moleski, 2000). It is suspected that treatment for ALL prior to the age of 5 
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can result in a disruption in myelinazation and cortical atrophy (Fletcher & Copeland, 
1988; Moleski, 2000; Reeb & Regan, 1998).  However, it is important to note that many 
of these conclusions are based upon performance on standardized IQ tests, which may 
be insensitive to subtle changes in neuropsychological performance. In addition, until 
recently there have not any neuropsychological instruments which have been 
empirically validated with pre-school age children. Thus, it could be that the arbitrary 
age distinction of under 5 versus over 5 is an artifact of the instruments being used as 
opposed to an actual age difference. Subsequently, age at diagnosis will be used as a 
covariate in this study to determine if it accounts for a significant amount of variance 
when using a developmentally-appropriate battery specifically designed for young 
children.  
Hypotheses 4: Females Will Evidence Lower Scores on All Measures of Neurocognitive 
Abilities in Comparison to Their Male Counterparts.  
Past research has conclusively shown that gender reliably predicts performance 
on neuropsychological measures among ALL survivors. Specifically, greater 
impairments have been noted among females. It is unclear at the present time where 
specific gender differences in neuropsychological functioning exist. For this reason, it is 
hypothesized that females will evidence lower scores on all measures of neurocognitive 
abilities in comparison to their male counterparts. 
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Hypotheses 5: Performance on the NEPSY Will Be Consistent with Past Research 
Studies Documenting the Impact of ALL upon Neuropsychological Functioning; 
Survivors Are Likely to Demonstrate Impairments in Sensorimotor Abilities, Attention, 
Memory, and Visuospatial Skills. 
The choice of which dependent measure(s) to use in evaluating the presence 
and magnitude of differences among various treatment groups can influence the 
outcome of a research study: past research has often relied upon intellectual measures 
which have been criticized for being insensitive to subtle changes in cognitive 
functioning, a poor indicator of neuropsychological functioning, and for using tasks that 
simultaneously measure more than one skill, thereby rendering the process of 
delineating underlying neurocognitive deficits extremely difficult. Furthermore, despite 
the plethora of research findings that suggest greater impairments among children 
treated at a younger age, there are few neuropsychological measures that have been 
empirically validated for use with pre-school age and younger children. To date, the 
NEPSY is the only comprehensive measure of neurocognitive performance that is 
intended for children under the age of 5. Thus, while this study is not the first to address 
neuropsychological functioning in pediatric ALL survivors, it is novel in its approach 
through the use of the NEPSY, a comprehensive neuropsychological battery specifically 
designed for use with children ages 3-12.  It is anticipated that the results of this study 
will support past research findings, although the magnitude and origin of neurocognitive 
impairments may vary in comparison. 
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Hypothesis 6: Performance On Neuropsychological Measures Will be Consistent with a 
Hierarchical Model in which Sensorimotor Abilities Account For the Most Variance, 
Followed by Attention, Memory, and Finally Visuomotor Skills. 
Consistent with the hierarchical model of neuropsychological functioning 
proposed by Aleksandr Luria, this research study seeks to delineate the individual 
contributions of more basic cognitive skills in predicting performance on 
neuropsychological measures using a step-wise procedure. That is, as opposed to 
treating all of the dependent variables as solitary measures that operate independent of 
each other and are of all equal magnitude, alterations in more basic cognitive skills (e.g. 
attention, fine motor skills) are given higher priority over higher-order processes (e.g. 
abstract reasoning, organization) in predicting neuropsychological functioning. Thus, it 
is hypothesized that performance on neuropsychological measures will be consistent 
with a hierarchical model in which sensorimotor abilities account for the most variance, 
followed by attention, memory, and finally visuomotor skills. Because this is the first 
study to employ a hierarchical model of neuropsychological functioning in ALL survivors, 
predictions regarding group differences will be explored via post-hoc analysis contingent 
upon significant main effects. 
Other Considerations 
While it would be intriguing to examine all domains of neuropsychological 
functioning among ALL survivors, past research has only consistently shown alterations 
in sensorimotor abilities, attention, memory, and visuospatial skills; efforts to elucidate 
the long-term effects upon language and executive functioning skills has resulted in 
equivocal finding (Brown & Madan-Swain, 1993; Fletcher & Copeland, 1988; Reeb & 
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Regan, 1998; Stehbens et al., 1994). This is consistent with the finding that ALL 
survivors evidence greater impairments in skills associated with the right hemisphere 
(Brown & Madan-Swain, 1993; Reeb & Regan, 1998; Stehbens et al., 1994). Further 
evidence to support a relationship between treatment for ALL and disruptions in 
nonverbal skills is provided by Packer et al. (1987), who note that methotrexate 
interferes with the production of a key lipid necessary for myelin formation. Because the 
right hemisphere has been shown to be the area of the most intense myelinization 
during childhood (Brown & Madan-Swain, 1993; Fletcher & Copeland, 1988; Moleski, 
2000; Reeb & Regan, 1998), it is logical to conclude that skills associated with this area 
will show the greatest decline. Thus, for the purposes of this study, only functioning in 
the following areas will be assessed: sensorimotor skills, attention, memory, and 
visuospatial abilities. 
 Finally, because executive functioning is mediated by the frontal lobes and not 
considered a lateralized ability, measures of processing speed, planning, and abstract 
reasoning will also be excluded from this study (Lezak, Howieson, & Loring, 2004). In 
addition, neither academic achievement nor general cognitive ability will be included as 
dependent measures based upon previous research which suggests that both are poor 
indicators of neuropsychological functioning (Butler & Copeland, 1993; Eiser, 1992; 
Moleski, 2000; Reeb & Regan, 1998). 
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All information was taken from a database maintained by the behavioral health 
department of a large, metropolitan, children’s specialty hospital. Only information for 
children ages 1-12 who had been treated for acute lymphocytic leukemia from 2002-
2005 and who were administered the core domains of the NEPSY were included in this 
study. 90 children (28 females, 52 males) ages 3 to 12 (M = 7.28 years, SD = 2.64) 
were evaluated. Patients ranged in age from 1 to 12 (M = 4.97 years, SD = 2.76) at 
initial diagnosis. Only test scores that were obtained a minimum of 2 years after the 
child’s final cancer treatment were included.   
Materials 
NEPSY Neuropsychological Battery for Children. The NEPSY is a comprehensive 
neuropsychological instrument intended for use with children ages 3-12. Based upon 
the Lurian model, the NEPSY yields five domain scores: sensorimotor abilities (fingertip 
tapping, imitating hand positions, visuomotor precision, manual motor sequences, finger 
discrimination), attention-executive (tower, auditory attention and response set, visual 
attention, statue), memory and learning (memory for faces, memory for names, 
narrative memory, sentence repetition, list learning), visuospatial skills (design copying, 
arrows, block construction, route finding), and language (body parts naming, 
phonological processing, speeded naming, comprehension of instructions, repetition of 
nonsense words, verbal fluency, oromotor sequencing) (Korkman, Kirk, & Kemp, 1998). 
Only the attention/executive, memory/learning, visuospatial, and sensorimotor domain 
scores were examined in this study. Functioning in each domain is comprised of 
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graduated subtests; there are 27 subtests in all (five sensorimotor, six attention-
executive, five memory/ learning, four visuospatial, and seven language) (Korkman et 
al., 1998). Raw scores were converted into age-based scaled scores. Individual subtest 
scores were not recorded during data collection and thus, were not available for more 
in-depth analysis. 
The NEPSY was standardized using a random sample of children and reflects 
adequate representation of minorities based upon 1995 Census Data (Korkman et al., 
1998). There are two forms; one is for children ages 3-4 and the other is for ages 5-12. 
The core domain scores have moderate-high internal consistency scores and are listed 
from lowest to highest as follows: sensorimotor (.79), attention/ executive (.82), 
visuospatial processing (.83), language (.87) and memory and learning (.87) (Ahmed & 
Warriner, 2001; Korkman et al., 1998). Stability coefficients for the domain scores are 
as follows: attention/ executive (.68), language (.78), sensorimotor (.77), visuospatial 
(.72), and memory and learning (.90) (Korkman et al., 1998). 
The NEPSY is intended as a flexible battery in which areas of weakness or 
strength can be further explored based upon performance on core domains. All 
individuals in this study were administered the core domain subtests; any additional 
neuropsychological testing was not included in this study. The subtests comprising the 
core battery are as follows: Sensorimotor - fingertip tapping, imitating hand positions, 
visuomotor precision; Attention/ Executive Functioning - tower, auditory attention and 
response set, visual attention; Memory/ Learning - memory for faces, memory for 
names, narrative memory; Visuospatial- design copying, arrows.   
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Design and Procedure 
 Although a 3 x 2 factorial MANCOVA was initially proposed, a review of the de-
identified database revealed that none of the subjects had received radiation alone; 
thus, the Treatment variable only had 2 levels, rendering a 2 x 2 design. Type of 
treatment (chemotherapy only vs. combined treatment) and Gender (male vs. female) 
were independent variables and the sensorimotor, attention/ executive, memory and 
learning, and visuospatial standard scores of the NEPSY were used as dependent 
variables. Each of these domains was analyzed sequentially via a Roy-Bargmann step 
down test so that performance differences due to more basic functions were eliminated 
prior to addressing higher-order neurocognitive functioning. Age at diagnosis (under age 
5 vs. over age 5) was used as a covariate. 
 To ensure confidentiality, all identifying information contained within the 
behavioral health department’s database was eliminated prior to being released to the 
principal investigator. Because all identifying information was removed prior to analyses, 
neither individual informed consent nor information concerning the availability of the 
results of this study were made available. 
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CHAPTER 3: RESULTS 
 
  A 2 x 2 between-subjects multivariate analysis of covariance was performed on 
four dependent variables: sensorimotor, attention/executive skills, memory/learning, and 
visuospatial abilities; the standard score for each of the above domains was used, as 
opposed to the individual subtests of the NEPSY.  Independent variables were gender 
and treatment modality; the covariate was a categorical age variable based on whether 
the child had been diagnosed with ALL prior to the age of 5.  
 A 2 x 2 between-subjects multivariate analysis of covariance was performed on 
four dependent variables: sensorimotor, attention/executive skills, memory/learning, and 
visuospatial abilities; the standard score for each of the above domains was used, as 
opposed to the individual subtests of the NEPSY.  Independent variables were gender 
and treatment modality; the covariate was a categorical age variable based on whether 
the child had been diagnosed with ALL prior to the age of 5.  
 MANCOVA was used for the analysis with the sequential adjustment for 
nonorthogonality. Order of entry was sensorimotor, attention/executive, 
memory/learning, and then visuospatial standard scores followed by the covariate. Total 
N of 91 was reduced to 81 due to missing NEPSY scores. There were no univariate or 
multivariate within-cell outliers at p < .001. Results of evaluation of assumptions of 
homogeneity of variance-covariance matrices, linearity, and multicollinearity were all 
within an acceptable range. However, there was an unequal distribution of patients in 
the chemotherapy-only versus combined treatment group when partitioned by gender: 
males (N = 33) and females (N=29) in the chemotherapy-only group significantly 
outnumbered males (N = 18) and females (N = 9) in the combined treatment group. 
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Examination of each group and their variances revealed that the largest amount of 
variance occurred within the chemotherapy-only female group and chemotherapy-only 
male group, respectively. The female combined group, which had the smallest cell size, 
showed the least amount of variance. FMax was judged to be within an average range, 
so in accordance with Tabachnick and Fidell (2001), the analysis proceeded.  
 The overall multivariate model, using Pillai’s criterion, was not significant, F (4, 
81) = .31302, p = .869. There were no interaction or main effects for treatment type or 
gender. Power for the overall multivariate model was determined to be poor (.117).  
Age at diagnosis (prior to age 5 vs. after age 5), served as a covariate. Age at 
diagnosis provided significant adjustment to sensorimotor skills, with ß = .334, t (77) = 
4.80, p = .002. Children diagnosed prior to the age of 5 had significantly lower scores on 
the NEPSY sensorimotor domain (M = 20.61, SD = 6.43) in comparison to children 
diagnosed at age 6 or older (M = 25.42, SD = 6.23). The covariate also provided 
significant adjustment to attention/executive functioning, with ß = .2266, t (77) = 3.163, p 
= .034. Children in the under age 5 category scored significantly lower on the 
attention/executive functioning domain (M = 24.35, SD = 6.37) in comparison to those in 
the age 6-12 category (M = 27.38, SD = 6.23). Finally, age at diagnosis was significant 
for memory, with ß = .338, t (77) = 5.66, p = .002.  Again, children in the younger age 
group scored significantly lower on the NEPSY memory domain (M = 24.93, SD = 7.80) 





To determine the influence of each main effect on the individual dependent 
measures, a Roy-Bargmann stepdown analysis was performed on the prioritized 
dependent variables (DVs). All variables were judged to be sufficiently reliable to 
warrant stepdown analysis. In stepdown analysis each DV was analyzed, in turn, with 
higher-priority DVs treated as covariates and with the highest-priority DV tested in a 
univariate ANOVA. Homogeniety of regression was achieved for all components of the 
stepdown analysis.  An experiment-wise error rate of 5% was achieved by the 
apportionment of alpha.  
 Exploratory analysis revealed a significant effect for NEPSY version, F (4,83) = 
2.97, p = .024. Children who were tested using the 3-4 year-old version (N = 47) of the 
NEPSY scored significantly lower on the sensorimotor, attention/executive, and memory 
domains in comparison to those tested using the 5-12 year-old (N = 43) version. This 
finding was independent of gender and years since diagnosis.  




CHAPTER 4: DISCUSSION 
 
 It was hypothesized that the six following factors would account for differences 
on neuropsychological measures among children treated for ALL: (1) treatment 
modality; (2) latency between final treatment and neuropsychological testing; (3) age at 
diagnosis; (4) gender; (5) choice of neurocognitive assessment material; and (6) a 
hierarchical structure in which more basic cognitive functions account for the greatest 
variance in scores followed by more abstract concepts.  A hierarchical model in which 
“lower order” (i.e. more basic) cognitive abilities were analyzed prior to more advanced 
skills in a step-wise fashion was accomplished via a Roy-Bargmann step-down test. The 
order in which variables were entered is as follows: sensorimotor skills, 
attention/executive functioning, memory/learning, and visuospatial abilities. Results are 
discussed as they relate to the initial 6 hypotheses.  
Hypothesis 1: Performance on Neuropsychological Measures Will Fall on a Continuum 
with the Combined Treatment Group Showing the Greatest Impairments, Followed by 
the Radiation-Only Group, and Then the Chemotherapy-Only Group. 
Because there were no children in the radiation-only group, comparisons were 
limited to the combined treatment and chemotherapy-only groups. Statistical analysis 
did not reveal any significant interactions or main effects for treatment type.  
No efforts were made to control for specific effects of different chemotherapeutic 
agents. Past research suggests that specific medications can affect some 
neurocognitive abilities more than others (Ghalie et al., 1990; Johnston, 1985; Mauer et 
al., 1983; Memon et al., 1995; Menegaux et al., 1994; Moleski, 2000; Nussbaum et al., 
1995). For instance, cisplatin has been linked with speech difficulties and memory 
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deficits (NCI, 2005) whereas methotrexate is associated with impairments in attention, 
processing speed, and hand-eye coordination (NCI, 2005). The deleterious effects of 
these agents may be augmented by radiation therapy; thus, treatment effects in this 
study may have been masked by failing to distinguish between specific drug protocols. 
Although treatment differences between children treated with chemotherapy 
alone versus combined chemotherapy/radiation were documented in this study, efforts 
were not made to control for relapses or subsequent rounds of therapy. Children who 
underwent a bone marrow transplant were not distinguished from those who were 
successfully treated with a single round of chemotherapy. Williams et al. (1986) argues 
that more aggressive treatment methods are likely to result in more severe deficits. 
Patchell et al. (1985) notes that in addition to the deleterious effects of chemotherapy 
and radiation, bone marrow transplant recipients are vulnerable to the risks of 
neurotoxicity arising from preparatory regimens, infections secondary to 
immunosuppression, and complications of the central nervous system as a result of 
multi-organ system failure. Transplant recipients may develop acute graft versus host 
disease, which is typically treated with corticosteroids; prolonged use of certain 
corticosteroids has been linked with reduced hippocampal size (Brown et al., 2004) and 
mental depression (Cool, 1991). However, previous attempts to isolate neurocognitive 
impairments following bone marrow transplant have been difficult as a result of 
heterogeneous populations and high mortality rates (Cool, 1991).   
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Hypothesis 2: Impairments in Neuropsychological Functioning Will be Apparent a 
Minimum of 2 Years Post-Treatment. 
While the precise period at which children treated for ALL begin to evidence 
neurocognitive impairments was not evaluated in this study, results do not support a 2 
year latency period. The precise latency between when a treatment course ends and 
when the child is evaluated using neurocognitive measures is an important factor that 
was not taken into consideration in this study. Given the non-linear development of 
neuropsychological abilities, it is difficult to determine at what point all neurological “late 
effects” will be evident (Brouwers et al., 1985; Brown & Madan-Swain, 1993; Fletcher & 
Copeland, 1988; Packer et al., 1987; Schatz et al., 2000; Stehbens et al., 1994). For 
instance, impairments in fine motor skills have been documented as early as 1 year 
post-treatment (Moleski, 2000) whereas difficulties in verbal processing and verbal 
memory may not be apparent until 3-5 years later (Mulhern et al., 1988; Précourt et al.,). 
As Packer et al., (1987) points out, few studies have made efforts to ensure that an 
adequate period of time has elapsed in order for late effects to emerge, choosing 
instead to just “randomly” guess. It is suggested that future studies allow a minimum of 
5 years between the final treatment session and neuropsychological evaluation. 
In addition, as De Luca et al. (2003) and Welsh et al. (1991) note, 
neuropsychological development varies for discrete functions and thus, the age of the 
child as well as the latency between treatment and neuropsychological testing must be 
taken into consideration.  For instance, improvements in vigilance are most notable 
between ages 4-6 whereas selective attention shows a bimodal pattern in which skills 
improve significantly from 4-6 and then later between ages 8-10 (Espy & Bull, 2005; 
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Klimkeit et al., 2004); thus, a child who is diagnosed at age 9 may not evidence 
problems in these areas. Support for this age/test latency interaction is evidenced by a 
study conducted by Stehbens et al. (1994), in which children were tested using the 
WISC-R, Token Test for Children, Rapid Automatized Naming Test, RAVLT, FAS 
Fluency, and Sentence Repetition Test. Results indicate that neurocognitive difficulties 
were evident 9 months post-treatment in children who were diagnosed before the age of 
5, but were not evident in those children who were older at diagnosis (Stehbens et al., 
1994). Thus, it could be that the older the child is at diagnosis, the longer it will take for 
late effects to emerge.  
Furthermore, measures of inhibition may be confounded by the delayed 
development of motor skills: according to a study conducted by Dowsett & Livesey 
(2000), young children were able to respond appropriately on measures of verbal 
inhibition but when given a task that required motor inhibition, they scored poorly. 
Efforts should be made to differentiate test items so that the influence of motor 
movements can be analyzed independent of processing speed and other 
neurocognitive abilities. 
Hypotheses 3: Performance On Neuropsychological Measures Will Vary with Age, with 
Children Who Were Diagnosed Prior to the Age of 5 Showing Greater Impairments in 
Comparison to Children Diagnosed with ALL After Age 5. 
Age was used as a covariate in this study and was statistically significant; 
children who were diagnosed prior to the age of 5 scored significantly lower on 3 of the 
4 dependent measures of the NEPSY: sensorimotor abilities, attention/executive 
functioning, and memory. It should be noted that while the cut-off age of 5 was based 
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upon past research studies, this is an arbitrary number. Efforts have focused on 
differences between pre-school age children and school-age children; a definitive age at 
which treatment for ALL poses less of a risk of neurocognitive impairments has not 
been established, although it is generally accepted that the younger a child is when 
treatment begins, the more likely one will experience difficulties with attention, memory, 
and sensorimotor skills.  
Although efforts were made to ensure use of measures that are appropriate for 
pediatric populations, this study did not take into account the developmental trajectory 
of neuropsychological functioning. Research indicates that neuropsychological skills do 
not develop in a linear fashion, but rather progress in spurts or stages (De Luca et al., 
2003; Espy & Bull, 2005). Executive functioning skills may be evident as early as 12 
months but do not stabilize until late adolescence or early adulthood (De Luca et al., 
2003).  
It also appears evident that the manner in which such skills are measured and 
how they are defined may differ by age. For instance, Zelazo et al. (2003) notes that 
cognitive inflexibility may be labeled as perseveration depending on what age 
population is being targeted. Furthermore, a single term may be used to indicate two 
different types of skills, as evidenced by the fact that “inhibition” can refer to both 
cognitive inflexibility and the failure to suppress an incorrect response despite 
awareness of the correct answer (Zelazo et al., 2003). 
Consistent with the findings that the validity and sensitivity of measures vary by 
age, similar tasks purported to gauge a specific construct may actually be assessing 
different skills depending on the age of the child (Beveridge et al., 2002; Hughes et al., 
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2002). As Hughes (2002) points out, the cognitive demands of a specific task such as 
the Tower of London may not be the same at age 8 as they are at age 6. Furthermore, 
differences on such tasks may reflect different factors in children than in adults; for 
instance, a depressed processing speed score may be the result of synaptic pruning in 
children in comparison to localized brain damage in an adult (Hale et al., 1997; 
Klenberg et al., 2001).   
In addition, the significant differences between the children diagnosed prior to 
age 5 and those diagnosed after age 6 may be an artifact of different versions of the 
same test for different age categories. Exploratory analysis revealed that children tested 
using the 3-4 year old version of the NEPSY scored significantly lower on the 
sensorimotor, attention/executive functioning, and memory domains in comparison to 
children tested using the 5-12 year old protocol. Although the two versions are very 
similar and contain many of the same subtests, the battery for older children is more 
extensive. It is possible that the battery for the 3-4 year old group is measuring different 
constructs than that of the 5-12 year old group and thus, any identified differences 
between the two groups would be a function of different constructs being measured as 
opposed to an actual effect for age. 
Hypotheses 4: Females Will Evidence Lower Scores on All Measures of Neurocognitive 
Abilities in Comparison to Their Male Counterparts. 
Males and females evidenced similar performance on all measures of 
neurocognitive functioning. However, males comprised 66% of the population; in 
combination with the low N, it is possible that power was insufficient in detecting gender 
differences. The absence of any significant gender differences may also be related to 
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the interaction of age and the use of generalized measures of attention/executive 
functioning. Males and females show distinct patterns of strengths and weaknesses 
among specific measures of attention, such as selective attention versus alternating 
attention (Klenberg et al., 2001). These patterns change as the child develops and then 
plateau in early adulthood (De Luca et al., 2003). For instance, in a study conducted by 
Klenberg et al. (2001), girls under the age of 6 had significantly higher scores on 
measures of inhibition, selective attention, and verbal fluency in comparison to their 
male counterparts; however, boys performed equally as well as girls on the same 
measures after age 6 (Klenberg et al., 2001).  
Hypotheses 5: Performance on the NEPSY Will Be Consistent with Past Research 
Studies Documenting the Impact of ALL upon Neuropsychological Functioning; 
Survivors Are Likely to Demonstrate Impairments in Sensorimotor Abilities, Attention, 
Memory, and Visuospatial Skills. 
Unlike past research studies, the results of this study did not support 
neurocognitive impairments in the areas of sensorimotor abilities, attention, memory, or 
visuospatial skills among ALL survivors beyond what was accounted for by age of 
diagnosis. While children diagnosed prior to age 5 showed impairments in sensorimotor 
abilities, attention, and memory, there were not any significant differences in 
neurocognitive skills among children age 6 or older. However, because this study 
focused on differences in neuropsychological functioning as a function of treatment 
modality, patients were not compared to a control group consisting of normal children. It 
is likely that children who were diagnosed after age 6 showed differences on 
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neurocognitive measures in comparison to children who have never been diagnosed 
with ALL.  
This lack of findings in contrast to the many well planned, ecologically sound, 
research studies of the past may be attributable to differences in the sensitivity of the 
dependent measure(s). Like many psychological assessment instruments, the NEPSY 
is comprised of several subtests that are intended to measure discrete functions such 
as processing speed and visual attention. Specific subtests are combined to yield an 
overall domain score, which is a more generalized measure of neurocognitive abilities. 
Past research has relied upon various measures which are comparable to the subtest 
scores of the NEPSY. Because the subtest scores of the NEPSY were not recorded for 
participants in this study, the generalized domain scores were used for comparison; 
thus, past studies reporting significant effects relied upon instruments with much greater 
sensitivity than those used in this study and thereby may have been better able to 
detect subtle differences. Future research should focus on comparison of individual 
subtest scores in contrast to global or domain scores. 
It should also be noted that while neurocognitive performance can be assessed 
via both quantitative and qualitative data, there is a tendency to rely more heavily upon 
quantitative measures as it is regarded as more objective (Anderson, 2002; Beveridge 
et al., 2002; Hughes, 2000). This limits the measure’s diagnostic utility as quantitative 
data does not reflect important behavioral patterns such as perseveration or specific 
error patterns (Anderson, 2002). In addition, quantitative data is limited by the “ceiling” 
effect, thereby masking changes in individuals who perform in the above average or 
superior range (Beveridge et al., 2002). Hughes (2000) emphasizes the need for both 
 52
 
quantitative and qualitative variables in studying neuropsychological performance. 
Although the NEPSY includes scoring information for qualitative data (e.g. number of 
omission versus commission errors), only the standardized scores for the domain 
scores were included in this study.  
An additional consideration is that the skills comprising neuropsychological 
domain scores may not be the same for pediatric populations as it is for adults, 
particularly in regard to executive functions. Indeed, how “executive functioning” is 
operationalized varies according to the population being studied (Carlson, 2005). Hala 
et al. (2003) posits that executive functioning, as seen in studies involving adult 
populations, is comprised of working memory, inhibitory control, and attention whereas 
Anderson (2002) defines pediatric executive function as consisting of attention, 
information processing, cognitive flexibility, and goal setting. Miyake et al. (p. 53, 2000, 
as cited in Beveridge et al., 2002) points out “the precise nature of executive processes 
implicated in the performance of these tasks is underspecified…there is a paucity of 
rigorous theoretical analysis and independent empirical evidence regarding what these 
executive tasks really measure.” 
Despite all of the studies documenting impairments in neuropsychological 
functioning following treatment for ALL, very few studies have actually performed 
statistical analyses pre to post-test to determine if these changes in scores are clinically 
significant. Moss et al. (1981) failed to find a statistically significant difference between a 
group of children tested 23 months post-treatment in comparison to children tested 47 
months post-treatment, despite decrements in performance on neuropsychological 
measures pre to post-treatment for both groups. Cancer-causing factors or agents may 
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result in cognitive impairments that are independent of the effects of treatment, age, or 
gender.  
Hypothesis 6: Performance On Neuropsychological Measures Will be Consistent with a 
Hierarchical Model in which Sensorimotor Abilities Account For the Most Variance, 
Followed by Attention, Memory, and Finally Visuomotor Skills. 
This study did not support a hierarchical framework of neuropsychological 
functioning. Statistical analysis did not reveal that lower order cognitive abilities account 
for more variance than higher order skills such as planning or problem-solving. It is 
suspected that this may have been attributable to the reduced power of the analysis as 
a result of the small population. While statistical power was gauged as “moderate,” the 
use of the NEPSY domain scores in lieu of individual subtest scores warrants the need 
for greater power, especially when cell sizes contain less than 20 observations. Future 
studies should be careful to balance the sensitivity of an instrument with the overall 
ability to detect a significant finding. 
Hierarchical neuropsychological functioning assumes that there are notable 
differentiations in skills which can be measured as distinct constructs. In adult 
populations, attention is viewed as operating in tandem with executive abilities although 
specific skills such as planning and cognitive flexibility can be easily isolated. It stands 
to reason, then, that children also show a differentiation of skills which would reveal 
specific deficits during a comprehensive assessment. However, several authors (e.g. 
Carlson, 2005; Espy & Bull, 2005) have posited that because of the uneven 
development of specific neurocognitive abilities, neuropsychological functioning may not 
be hierarchically structured in childhood, but rather consist of generalized abilities that 
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develop into highly specialized skills during the latter part of adolescence and early 
adulthood. Consistent with this hypothesis, Schmitt et al. (2004) found that the 
attention/executive functioning domain of the NEPSY did not differentiate between 
brain-injured and non brain-injured subjects. In fact, only the language and sensorimotor 
domains of the NEPSY were effective in discriminating between the two groups; the 
memory and learning domain was unaffected by changes in visual memory and the 
visuospatial domain provided no discriminate validity at all (Schmitt et al., 2004). De 
Luca et al. (2003) found similar results when assessing set-shifting abilities among 8 
and 10 year-old children. In addition, Espy and Bull (2005) found no differences in 4-5 
year-olds when evaluating the influence of proactive interference versus resistance to 
distraction.  
However, as Carlson (2005) points out, neuropsychological measures are often 
factorially complex; many tasks purported to be “pure” measures of a specific skill may 
actually tap into several different abilities. Since the core domain of the NEPSY is 
intended as a neuropsychological screener, it is possible that the relative weakness of 
the attention/executive, visuospatial, and memory/learning domain scores in 
differentiating brain-injured from non brain-injured subjects may be attributable to the 
instrument’s insensitivity to subtle differences rather than a lack of skill differentiation. 
Finally, the unique contribution of genetics, brain development, and different 
treatment modalities may have resulted in such distinct pattern of strengths and 
weaknesses that broad generalizations about the population cannot be accurately 
inferred. Rourke (1989) notes that one of the most common errors in studies focusing 
on pediatric populations is assuming that every child with a given illness will show the 
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same response pattern throughout development. However, two children with the same 
medical diagnosis may show very different neuropsychological profiles depending on 
treatment variables, developmental stage of brain at initial diagnosis, frequency and use 
of interventions to remediate deficits, and other factors. Detailed information about 
these factors should be included in future research studies to reduce confounding 
effects. 
Taken all together, the results of this study do not support a hierarchical structure 
of neuropsychological abilities in children treated for ALL. However, general conclusions 
are tenuous due to the unequal distribution of subjects in the male and female 
chemotherapy groups in comparison to the male and female combined treatment 
groups. Age at diagnosis (before age 5 versus after age 6) appears to be a strong 
predictor of long-term cognitive functioning. Based on the results of past studies, it 
appears evident that there is a latency between when treatment ends and when 
neurocognitive impairments become evident; however, the exact time frame in which 
deficits emerge remains unknown. Finally, the failure to control for specific 
chemotherapeutic agents may have resulted in masking group differences.   
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CHAPTER 5: IMPLICATIONS 
 
 The results of this study have important implications for clinicians who work with 
children being treated for ALL.  The relationship among age at diagnosis, treatment 
modality, latency of testing, and neurocognitive abilities appears to be more complicated 
than originally believed; thus, one cannot accurately deduce that all children treated for 
ALL will manifest the same pattern of impairments. Clinicians should be cognizant of the 
fact that neuropsychological functioning does not proceed in a linear fashion and 
therefore, assessment should focus on the skills that are developmentally appropriate 
for the child (Carlson, 2005; De Luca et al., 2003; Espy & Bull, 2005). For instance, 
measures of inhibition in young children should be limited to verbal tasks as studies 
have shown that motor skills are not fully developed until a later period in time (Dowsett 
& Livesey, 2000). Abstract reasoning does not stabilize until adolescence and therefore, 
results pertaining to this skill in young children are likely to be confounded by 
developmental limitations (Espy & Bull, 2005; Klimkeit et al., 2004). 
 Furthermore, it appears evident that assessment of neurocognitive functioning 
should focus on specific constructs as opposed to general domains (Beveridge et al., 
2002; Hughes et al., 2002). Improvements in selective attention are likely to be masked 
by a domain score that reflects performance on vigilance, inhibition, and sustained 
attention (Klenberg et al., 2001). Alterations in visual memory, which would be 
consistent with the theory of greater right hemisphere dysfunction,  “disappear” when 
combined with verbal memory to get an overall memory score (Klenberg et al., 2001; 
Schmitt et al., 2004). Clinicians should be encouraged to only evaluate specific 
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constructs depending on the child’s developmental level as opposed to doing broad 
screenings. 
 The results of this study further implicate a need for frequent, thorough 
evaluation of the child’s academic progress and increased communication between 
medical professionals and school staff. ALL survivors are at an increased risk for 
problems with various neuropsychological skills dependent upon the interaction of 
several factors. Teachers should be apprised of a child’s academic weaknesses and 
given suggestions for effective classroom accommodations. 
 Furthermore, for children who have been treated for ALL who are at an increased 
risk for learning problems due to genetics or specific chemotherapeutic agents, 
preventative techniques aimed at reducing the severity of neurocognitive impairments 
should be implemented. Several promising studies (e.g. Butler & Mulhern, 2005) 
suggest that the use of certain cognitive-behavioral strategies, mental activities, and 
medication may be effective in moderating impairments in attention and memory.  
 Finally, this study suggests that not all treatments for ALL result in neurocognitive 
impairment. Many children who are successfully treated with milder chemotherapeutic 
agents intravenously do not evidence the expected deficits in cognitive functioning. 
Clinicians should be familiar with the most commonly used chemotherapeutic agents 
and the accompanying side effects which could result in decreased attention, memory, 






 Subject Characteristics 
 
                Males   Females  Total
Number      51       38     89 
Mean age at diagnosis*    5.25      4.63     4.97 
Mean age at testing*    7.59      6.92     7.28 
Time since diagnosis*    2.83      2.76     2.80 
Treatment     
 Chemotherapy only    33       29      62 
 Chemotherapy + radiation   18                                 9                           27 
 











Overall power = .117 (poor) 
 
Variable Value  Exact F Hypothesis DF Error DF Significance 
 
Pillais  .015  .313   4      81   .869 
 
Roy-Bargman Stepdown F-tests 
Variable  Stepdown F  DF  Hypothesis DF Significance 
Sensorimotor Skills  .259  1   84        .612 
Attention/Executive   .002  1   83                  .963 
Memory/Learning  .982  1   82          .325 





: Mean NEPSY Standard Scores as a Function of Gender and Treatment Modality  
 
     ______________________________NEPSY Standard Scores____________________ 
     Sensorimotor Attention/Executive  Memory/Learning  Visuospatial  
 
Chemotherapy only   22.13    24.64    27.01    16.85 
Female (N=29)  22.67    23.94    26.00    17.45 
Male (N=33)   21.66    25.50    27.89    16.32  
 
Chemotherapy + radiation  22.21    26.91    26.32    16.28 
 Female (N=9)  20.96    24.81    25.77    16.32 







 Significance of Covariate (Age of Diagnosis) on NEPSY Domain Scores  
 
 
Dependent Variable  B  Beta  Std. Error  t-value Significance  
Sensorimotor Skills  4.80  .334     1.49   3.223   .002 
Attention/Executive  3.16  .226     1.46   2.160   .034 
Memory/Learning  5.56  .338     1.70   3.271   .002 




Comparison of Performance on NEPSY Core Domains by Age Group (Covariate)  
 
 Dependent Measure  Mean   Standard Deviation   
 
Sensorimotor *           
   Under Age 5  20.04    6.41  
   Over Age 5  24.47    6.35    
  Attention/Executive* 
Under Age 5  23.96    6.68 
   Over Age 5  26.82    6.11 
  Memory/Learning* 
   Under Age 5  24.73    7.91 
   Over Age 5  28.90    7.01 
  Visuospatial Abilities 
   Under Age 5  15.87    4.88 
   Over Age 5  17.66    6.20 
                                                                                     








Power= .258 (poor) 
 
Test   Value  Exact  F Hypothesis DF Error DF  Significance 
Pillais Trace  .0482  1.026   4      81    .399 
 
 
Roy-Bargman Stepdown F-tests 
Variable        Stepdown F  DF  Hypothesis DF  Significance
Sensorimotor Skills     .148   1   84    .701 
Attention/Executive   2.608   1   83    .110 
Memory/Learning     .383   1   82    .537 










Power= .255 (poor) 
 
Test  Value  Exact  F Hypothesis DF Error DF Significance 
Pillais  .0629  1.361   4      81   .255 
 
 
Roy-Bargman Stepdown F-tests 
Variable   Stepdown F  DF Hypothesis DF Significance
Sensorimotor Skills   .038   1  84  .845 
Attention/Executive   3.502   1  83  .065 
Memory/Learning     .533   1  82  .467 
Visuospatial Abilities  1.371   1  81  .245 





Correlation Coefficients Between Dependent and Independent Variables  
 
   Age at            Age         Gender          TX        Sens-motor Atten/Exec       Mem/Learn    Visuospat 
Diagnosis  Tested                                       SS      SS          SS                 SS                              
_________________________________________________________________________________________ 
Treatment Type         -.121            -.108        -.125                             .006                 .160                    -.041                -.047          
  
Age at diagnosis       .366**       -.108            -.121 .322**    .196          .308        .113 
Age when tested         .366**                          -.137      -.108 .248*    .197            .220*  .026 
Gender                       -.108 -.137        -.125        .014   -.125          -.087  .171 
 
Table 9 
NEPSY Domain Scores by Age-Related Protocol  
(3-4 year old protocol versus 5-12 protocol) 
 
 
Test  Value  Exact  F Hypothesis DF Error DF Significance 
Pillai's  .125     2.97   4      83   .024 
 
 
 Dependent Measure  Mean   Standard Deviation 
 Sensorimotor*          
  Age 3-4 Version   19.64    1.02  
  Age 5-12 Version   24.87    1.07  
 Attention/Executive* 
  Age 3-4 Version   23.62    1.01  
  Age 5-12 Version   27.18    1.07 
Memory/Learning*  
  Age 3-4 Version   24.73    1.20  
  Age 5-12 Version   28.90    1.27 
Visuospatial Abilities 
  Age 3-4 Version   15.82    0.89  
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